184 related articles for article (PubMed ID: 11847213)
1. Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists.
Mallee JJ; Salvatore CA; LeBourdelles B; Oliver KR; Longmore J; Koblan KS; Kane SA
J Biol Chem; 2002 Apr; 277(16):14294-8. PubMed ID: 11847213
[TBL] [Abstract][Full Text] [Related]
2. Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.
Hilairet S; Foord SM; Marshall FH; Bouvier M
J Biol Chem; 2001 Aug; 276(31):29575-81. PubMed ID: 11387328
[TBL] [Abstract][Full Text] [Related]
3. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
4. Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding.
Moore EL; Gingell JJ; Kane SA; Hay DL; Salvatore CA
Biochem Biophys Res Commun; 2010 Mar; 394(1):141-5. PubMed ID: 20188075
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the human receptor activity-modifying protein 1 extracellular domain.
Kusano S; Kukimoto-Niino M; Akasaka R; Toyama M; Terada T; Shirouzu M; Shindo T; Yokoyama S
Protein Sci; 2008 Nov; 17(11):1907-14. PubMed ID: 18725456
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin receptor-like receptor and receptor activity modifying protein 1 in the rat dorsal horn: localization in glutamatergic presynaptic terminals containing opioids and adrenergic alpha2C receptors.
Marvizón JC; Pérez OA; Song B; Chen W; Bunnett NW; Grady EF; Todd AJ
Neuroscience; 2007 Aug; 148(1):250-65. PubMed ID: 17614212
[TBL] [Abstract][Full Text] [Related]
7. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
Thota C; Gangula PR; Dong YL; Yallampalli C
Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
[TBL] [Abstract][Full Text] [Related]
8. Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs).
Fischer JA; Muff R; Born W
Biochem Soc Trans; 2002 Aug; 30(4):455-60. PubMed ID: 12196114
[TBL] [Abstract][Full Text] [Related]
9. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
Kikumoto K; Katafuchi T; Minamino N
Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
[TBL] [Abstract][Full Text] [Related]
10. Respective roles of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMP) in cell surface expression of CRLR/RAMP heterodimeric receptors.
Flahaut M; Rossier BC; Firsov D
J Biol Chem; 2002 Apr; 277(17):14731-7. PubMed ID: 11854283
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and characterization of mouse calcitonin gene-related peptide receptor.
Miyauchi K; Tadotsu N; Hayashi T; Ono Y; Tokoyoda K; Tsujikawa K; Yamamoto H
Neuropeptides; 2002 Feb; 36(1):22-33. PubMed ID: 12147211
[TBL] [Abstract][Full Text] [Related]
12. Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74.
Miller PS; Barwell J; Poyner DR; Wigglesworth MJ; Garland SL; Donnelly D
Biochem Biophys Res Commun; 2010 Jan; 391(1):437-42. PubMed ID: 19914210
[TBL] [Abstract][Full Text] [Related]
13. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor.
Fraser NJ; Wise A; Brown J; McLatchie LM; Main MJ; Foord SM
Mol Pharmacol; 1999 Jun; 55(6):1054-9. PubMed ID: 10347248
[TBL] [Abstract][Full Text] [Related]
14. Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells.
Aldecoa A; Gujer R; Fischer JA; Born W
FEBS Lett; 2000 Apr; 471(2-3):156-60. PubMed ID: 10767413
[TBL] [Abstract][Full Text] [Related]
15. The extracellular domain of receptor activity-modifying protein 1 is sufficient for calcitonin receptor-like receptor function.
Fitzsimmons TJ; Zhao X; Wank SA
J Biol Chem; 2003 Apr; 278(16):14313-20. PubMed ID: 12574158
[TBL] [Abstract][Full Text] [Related]
16. Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure.
Cueille C; Pidoux E; de Vernejoul MC; Ventura-Clapier R; Garel JM
Biochem Biophys Res Commun; 2002 Jun; 294(2):340-6. PubMed ID: 12051717
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling.
Kamitani S; Sakata T
Biochim Biophys Acta; 2001 May; 1539(1-2):131-9. PubMed ID: 11389975
[TBL] [Abstract][Full Text] [Related]
18. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
Zumpe ET; Tilakaratne N; Fraser NJ; Christopoulos G; Foord SM; Sexton PM
Biochem Biophys Res Commun; 2000 Jan; 267(1):368-72. PubMed ID: 10623626
[TBL] [Abstract][Full Text] [Related]
19. The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors.
Kuwasako K; Kitamura K; Ito K; Uemura T; Yanagita Y; Kato J; Sakata T; Eto T
J Biol Chem; 2001 Dec; 276(52):49459-65. PubMed ID: 11591721
[TBL] [Abstract][Full Text] [Related]
20. Functional expression of heteromeric calcitonin gene-related peptide and adrenomedullin receptors in yeast.
Miret JJ; Rakhilina L; Silverman L; Oehlen B
J Biol Chem; 2002 Mar; 277(9):6881-7. PubMed ID: 11733510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
